Lasse Dahl Jensen1. 1. Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 17177 Stockholm, Sweden; Department of Medical and Health Sciences, Linköpings University, 581 85 Linköping, Sweden. Electronic address: lasse.jensen@liu.se.
Abstract
BACKGROUND: Cancer is considered to develop due to disruptions in the tissue microenvironment in addition to genetic disruptions in the tumor cells themselves. The two most important microenvironmental disruptions in cancer are arguably tissue hypoxia and disrupted circadian rhythmicity. Endothelial cells, which line the luminal side of all blood vessels transport oxygen or endocrine circadian regulators to the tissue and are therefore of key importance for circadian disruption and hypoxia in tumors. SCOPE OF REVIEW: Here I review recent findings on the role of circadian rhythms and hypoxia in cancer and metastasis, with particular emphasis on how these pathways link tumor metastasis to pathological functions of blood vessels. The involvement of disrupted cell metabolism and redox homeostasis in this context and the use of novel zebrafish models for such studies will be discussed. MAJOR CONCLUSIONS: Circadian rhythms and hypoxia are involved in tumor metastasis on all levels from pathological deregulation of the cell to the tissue and the whole organism. Pathological tumor blood vessels cause hypoxia and disruption in circadian rhythmicity which in turn drives tumor metastasis. Zebrafish models may be used to increase our understanding of the mechanisms behind hypoxia and circadian regulation of metastasis. GENERAL SIGNIFICANCE: Disrupted blood flow in tumors is currently seen as a therapeutic goal in cancer treatment, but may drive invasion and metastasis via pathological hypoxia and circadian clock signaling. Understanding the molecular details behind such regulation is important to optimize treatment for patients with solid tumors in the future. This article is part of a Special Issue entitled Redox regulation of differentiation and de-differentiation.
BACKGROUND:Cancer is considered to develop due to disruptions in the tissue microenvironment in addition to genetic disruptions in the tumor cells themselves. The two most important microenvironmental disruptions in cancer are arguably tissue hypoxia and disrupted circadian rhythmicity. Endothelial cells, which line the luminal side of all blood vessels transport oxygen or endocrine circadian regulators to the tissue and are therefore of key importance for circadian disruption and hypoxia in tumors. SCOPE OF REVIEW: Here I review recent findings on the role of circadian rhythms and hypoxia in cancer and metastasis, with particular emphasis on how these pathways link tumor metastasis to pathological functions of blood vessels. The involvement of disrupted cell metabolism and redox homeostasis in this context and the use of novel zebrafish models for such studies will be discussed. MAJOR CONCLUSIONS: Circadian rhythms and hypoxia are involved in tumor metastasis on all levels from pathological deregulation of the cell to the tissue and the whole organism. Pathological tumor blood vessels cause hypoxia and disruption in circadian rhythmicity which in turn drives tumor metastasis. Zebrafish models may be used to increase our understanding of the mechanisms behind hypoxia and circadian regulation of metastasis. GENERAL SIGNIFICANCE: Disrupted blood flow in tumors is currently seen as a therapeutic goal in cancer treatment, but may drive invasion and metastasis via pathological hypoxia and circadian clock signaling. Understanding the molecular details behind such regulation is important to optimize treatment for patients with solid tumors in the future. This article is part of a Special Issue entitled Redox regulation of differentiation and de-differentiation.
Authors: Ruhina S Laskar; Peng Li; Szilvia Ecsedi; Behnoush Abedi-Ardekani; Geoffroy Durand; Nivonirina Robinot; Jean-Noël Hubert; Vladimir Janout; David Zaridze; Anush Mukeria; Dana Mates; Ivana Holcatova; Lenka Foretova; Beata Swiatkowska; Zoran Dzamic; Sasa Milosavljevic; Robert Olaso; Anne Boland; Jean-François Deleuze; David C Muller; James D McKay; Paul Brennan; Florence Le Calvez-Kelm; Ghislaine Scelo; Estelle Chanudet Journal: Hum Mol Genet Date: 2021-04-27 Impact factor: 6.150
Authors: Giuseppe Bellastella; Maria Ida Maiorino; Lorenzo Scappaticcio; Annamaria De Bellis; Silvia Mercadante; Katherine Esposito; Antonio Bellastella Journal: Life (Basel) Date: 2021-05-10
Authors: Daniel L Pouliquen; Alice Boissard; Cécile Henry; Olivier Coqueret; Catherine Guette Journal: Front Pharmacol Date: 2022-07-08 Impact factor: 5.988
Authors: Matias Estaras; Manuel R Gonzalez-Portillo; Miguel Fernandez-Bermejo; Jose M Mateos; Daniel Vara; Gerardo Blanco-Fernandez; Diego Lopez-Guerra; Vicente Roncero; Gines M Salido; Antonio González Journal: Int J Mol Sci Date: 2021-05-24 Impact factor: 5.923